NEW YORK (GenomeWeb News) – The US Food and Drug Administration has cleared for marketing Hologic's two assays for human papillomavirus testing, making it the second firm to gain FDA clearance to sell a molecular diagnostic for the condition in the US.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genomic analysis of high-grade serous ovarian cancer, and more.

The new Riken president outlines some of his plans for the institute.

The Guardian discusses whether big science projects are worth the loss of resources available for other scientific pursuits.

An NEJM update from the ClinVar team highlights the difficulties of interpreting genetic variants.